Joel Greenblatt’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.9K Buy
+16,299
New +$72.3K ﹤0.01% 1853
2024
Q3
– Sell
-33,285
Closed -$636K – 1448
2024
Q2
$636K Sell
33,285
-18,738
-36% -$479K 0.01% 1019
2024
Q1
$1.71M Buy
+52,023
New +$1.66M 0.03% 696
2022
Q4
– Sell
-24,538
Closed -$882K – 1239
2022
Q3
$882K Buy
24,538
+7,790
+47% +$274K 0.03% 692
2022
Q2
$514K Buy
16,748
+9,657
+136% +$281K 0.02% 776
2022
Q1
$229K Buy
+7,091
New +$186K 0.01% 1034
2017
Q3
– Sell
-13,472
Closed -$342K – 947
2017
Q2
$342K Buy
+13,472
New +$324K ﹤0.01% 812

Other funds holding EVH

Joel Greenblatt's EVH Position: Q3 2026 in Review

Joel Greenblatt opened a new position in Evolent Health (EVH) in Q3 2026: 16,299 shares worth $56.9K. The stake represents ﹤0.01% of the portfolio and ranks #1853 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in EVH as recently as Q2 2024.

Joel Greenblatt first reported a position in EVH in Q2 2017 and has held it in 7 quarters since. The position peaked at $1.71M in Q1 2024. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Joel Greenblatt held 16,299 shares of Evolent Health worth $56.9K as of Q3 2026.
  • Evolent Health was a new Joel Greenblatt position in Q3 2026.
  • Evolent Health made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1853 holding.
  • Joel Greenblatt first reported a position in Evolent Health in Q2 2017 and has held it in 7 quarters since.
  • Joel Greenblatt's Evolent Health position peaked at $1.71M in Q1 2024.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.